Recent Transactions

20-May-13
$8.5 billion
Ireland flag
Target: 

Warner Chilcott, plc

United States flag
Acquiror: 
Actavis, Inc.

Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc

08-May-13
$110 million
United States flag
Target: 

Healthcare Finance Group, LLC

United States flag
Acquiror: 
Fifth Street Finance Corp.

Advised Fifth Street Finance Corp., a specialty finance company with approximately $2 billion of assets under management, on the acquisition of Healthcare Finance Group, LLC, a specialty lender providing asset-based lending and term loan products to the healthcare industry

25-Apr-13
$3.8 billion
Australia flag
Target: 

GrainCorp Limited

United States flag
Acquiror: 
Archer Daniels Midland Company

Advised GrainCorp Limited on the unsolicited takeover offer from Archer Daniels Midland Company, a global agribusiness that converts oilseeds, corn, wheat and cocoa into products for food, animal feed and energy uses

21-Dec-12
$3.7 billion
Finland, U.S.A. flags
Target: 

NewPage Corp.

Advised Stora Enso Oyj, a global paper, packaging and wood products producer headquartered in Helsinki, Finland, in connection with the Chapter 11 proceeding of NewPage, the largest North American coated-paper manufacturer

11-Dec-12
$51.6 billion
United States flag
Target: 

American International Group (AIG)

Advised the United States Department of the Treasury (“UST”) on the full reduction of its 92% ownership stake in the insurer through numerous Secondary Public Offering Transactions

30-Oct-12
$834 million
U.S.A., Guernsey flags
Target: 

Investments of AP Alternative Assets, L.P.

U.S., Bermuda flags
Acquiror: 
Athene Holding Ltd.

Advised the Special Committee of the Conflicts Committee of the Board of Directors of Athene Holding Ltd. in connection with the purchase of non-cash investment assets of AP Alternative Assets L.P.

23-Oct-12
$5.7 billion
United States flag
Target: 

Target Corporation’s REDcard credit card assets

U.S.A., Canada flags
Acquiror: 
The Toronto-Dominion Bank Group

Advised The Toronto-Dominion Bank Group on its acquisition of Target Corporation’s REDcard credit card assets

03-Oct-12
$NA
United States flag
Target: 

Guardian Industries

United States flag
Acquiror: 
Koch Industries

Advised the Special Committee of the Board of Directors of Guardian Industries, one of the world’s leading glass manufacturers, in connection with its recapitalization and sale of a minority stake to Koch Industries

27-Sep-12
$1.5 billion
United States flag
Target: 

The Hartford’s Individual Life Insurance Business

United States flag
Acquiror: 
Prudential Financial, Inc.

Advised The Hartford, a leading provider of insurance and wealth management services, on the divestiture of its Individual Life Insurance Business to Prudential Financial, Inc.

20-Sep-12
$1.0 billion
United States flag
Target: 

Becker Underwood

Germany flag
Acquiror: 
BASF

Advised Norwest Equity Partners on the sale of its portfolio company Becker Underwood, a global leader in the development and commercialization of yield-improving seed-applied biological products for the Agricultural market, to BASF, the world’s largest chemical company

04-Sep-12
$600 million
United States flag
Target: 

The Hartford’s Retirement Plans Group

United States flag
Acquiror: 
Massachusetts Mutual Life Insurance Company

Advised The Hartford, a leading provider of insurance and wealth management services, on the divestiture of its Retirement Plans Group to Massachusetts Mutual Life Insurance Company, a leading mutual life insurance company

30-Aug-12
$4.9 billion
United States flag
Target: 

Performance Coatings division of E. I. DuPont de Nemours and Company

United States flag
Acquiror: 
The Carlyle Group

Advised E. I. Du Pont de Nemours and Company, a global diversified chemicals company, on the sale of its Performance Coatings division to an affiliate of The Carlyle Group, a leading private equity firm

20-Aug-12
$7.3 billion
United States flag
Target: 

Coventry Health Care Inc.

United States flag
Acquiror: 
Aetna

Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna

21-May-12
$NA
United States flag
Target: 

Polar Ware Company

United States flag
Acquiror: 
The Vollrath Company

Advised Polar Ware Company, a food equipment company with a broad product portfolio including soft-serve ice cream and frozen yogurt machines and food serving equipment and smallwares, on its sale to The Vollrath Company, a manufacturer of foodservice products

27-Apr-12
$NA
United States flag
Target: 

Merlin Securities LLC

United States flag
Acquiror: 
Wells Fargo & Company

Advised Merlin Securities LLC, a leading prime brokerage company in the US, on its sale to Wells Fargo

28-Mar-12
$10.4 billion+
United States flag
Target: 

Flow Control Business of Tyco International Ltd.

United States flag
Acquiror: 
Pentair, Inc.

Provided fairness opinion to the Board of Directors of Pentair, Inc. in connection with its all-stock merger with Tyco Flow Control, a division of Tyco International Ltd. (+Transaction value represents enterprise value of combined entity)

26-Mar-12
$513 million
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

United States flag
Acquiror: 
Bausch + Lomb, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its sale to Bausch + Lomb, Inc., a global ophthalmic products company

16-Dec-11
$NA
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives

29-Nov-11
$NA
United States flag
Target: 

Pension Benefit Guaranty Corporation

Advised the Pension Benefit Guaranty Corporation (“PBGC”) in connection with the Chapter 11 filing of AMR Corporation, the parent company of American Airlines, Inc. and American Eagle Airlines, Inc.

21-Nov-11
$689 million
Australia flag
Target: 

iNova Pharmaceuticals

United States flag
Acquiror: 
Valeant Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals

17-Nov-11
$860 million
United States flag
Target: 

MeadWestvaco’s Consumer & Office Products Division

United States flag
Acquiror: 
ACCO Brands Corporation

Provided fairness opinion to the Board of Directors of MeadWestvaco Corporation on the spin-off and subsequent merger of its Consumer & Office Products Division with ACCO Brands Corporation

07-Nov-11
$398 million
United States flag
Target: 

American Dental Partners, Inc.

United States flag
Acquiror: 
JLL Partners

Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm

10-Aug-11
$65 million
Mexico flag
Target: 

Grupo Aeromexico S.A. de C.V

United States flag
Acquiror: 
Delta Air Lines, Inc.

Advised Delta Air Lines, Inc. in connection with its strategic minority investment in Grupo Aeromexico S.A. de C.V

19-Jul-11
$418 million
United States flag
Target: 

Lochinvar Corporation

United States flag
Acquiror: 
A. O. Smith Corporation

Advised A. O. Smith Corporation, a leading manufacturer of water heating equipment, water treatment products and water system tanks, on the acquisition of Lochinvar Corporation, a private manufacturer and distributor of high efficiency boilers

30-Jun-11
$609 million
Japan flag
Target: 

Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion

United States flag
Acquiror: 
Royalty Pharma

Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion

Pages

show all